These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8543166)

  • 41. Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element.
    Vickers T; Baker BF; Cook PD; Zounes M; Buckheit RW; Germany J; Ecker DJ
    Nucleic Acids Res; 1991 Jun; 19(12):3359-68. PubMed ID: 2062653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus.
    Kim SG; Hatta T; Tsukahara S; Nakashima H; Yamamoto N; Shoji Y; Takai K; Takaku H
    Bioorg Med Chem; 1995 Jan; 3(1):49-54. PubMed ID: 8612046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of HIV replication by immunoliposomal antisense oligonucleotide.
    Selvam MP; Buck SM; Blay RA; Mayner RE; Mied PA; Epstein JS
    Antiviral Res; 1996 Dec; 33(1):11-20. PubMed ID: 8955849
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
    Peng H; Callison D; Li P; Burrell C
    Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phase.
    Nagy K; Young M; Baboonian C; Merson J; Whittle P; Oroszlan S
    J Virol; 1994 Feb; 68(2):757-65. PubMed ID: 8289379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rev-binding aptamer and CMV promoter act as decoys to inhibit HIV replication.
    Konopka K; Lee NS; Rossi J; Düzgüneş N
    Gene; 2000 Sep; 255(2):235-44. PubMed ID: 11024283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Rev-inducible mutant gag gene stably transferred into T lymphocytes: an approach to gene therapy against human immunodeficiency virus type 1 infection.
    Smythe JA; Sun D; Thomson M; Markham PD; Reitz MS; Gallo RC; Lisziewicz J
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3657-61. PubMed ID: 8170964
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
    Chen H; He J; Fong S; Wilcox G; Wood C
    J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persistence of attenuated HIV-1 rev alleles in an epidemiologically linked cohort of long-term survivors infected with nef-deleted virus.
    Churchill MJ; Chiavaroli L; Wesselingh SL; Gorry PR
    Retrovirology; 2007 Jul; 4():43. PubMed ID: 17601342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator.
    Bevec D; Dobrovnik M; Hauber J; Böhnlein E
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9870-4. PubMed ID: 1409715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. c-Myb influences HIV type 1 gene expression and virus production.
    Churchill MJ; Ramsay RG; Rhodes DI; Deacon NJ
    AIDS Res Hum Retroviruses; 2001 Nov; 17(16):1481-8. PubMed ID: 11709092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relative levels of inhibition of p24 gene expression by different 20-mer antisense oligonucleotide sequences targeting nucleotides + 1129 to + 1268 of the HIV-1 gag genome: an analysis of mechanism.
    Anazodo MI; Duta E; Friesen AD; Wright JA
    Biochem Biophys Res Commun; 1996 Dec; 229(1):305-9. PubMed ID: 8954123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term suppression of HIV-1C virus production in human peripheral blood mononuclear cells by LTR heterochromatization with a short double-stranded RNA.
    Singh A; Palanichamy JK; Ramalingam P; Kassab MA; Bhagat M; Andrabi R; Luthra K; Sinha S; Chattopadhyay P
    J Antimicrob Chemother; 2014 Feb; 69(2):404-15. PubMed ID: 24022068
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of HIV-1 replication by RNA targeted against the LTR region.
    Puerta-Fernández E; Barroso-del Jesus A; Romero-López C; Tapia N; Martínez MA; Berzal-Herranz A
    AIDS; 2005 Jun; 19(9):863-70. PubMed ID: 15905666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acquisition of HIV-1 resistance in T lymphocytes using an ACA-specific E. coli mRNA interferase.
    Chono H; Matsumoto K; Tsuda H; Saito N; Lee K; Kim S; Shibata H; Ageyama N; Terao K; Yasutomi Y; Mineno J; Kim S; Inouye M; Kato I
    Hum Gene Ther; 2011 Jan; 22(1):35-43. PubMed ID: 20649483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trafficking through the Rev/RRE pathway is essential for efficient inhibition of human immunodeficiency virus type 1 by an antisense RNA derived from the envelope gene.
    Ward AM; Rekosh D; Hammarskjold ML
    J Virol; 2009 Jan; 83(2):940-52. PubMed ID: 18971264
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages.
    Balotta C; Lusso P; Crowley R; Gallo RC; Franchini G
    J Virol; 1993 Jul; 67(7):4409-14. PubMed ID: 8510229
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of replication of fresh HIV type 1 patient isolates by a polypurine tract-specific self-complementary oligodeoxynucleotide.
    Jendis J; Strack B; Volkmann S; Böni J; Mölling K
    AIDS Res Hum Retroviruses; 1996 Aug; 12(12):1161-8. PubMed ID: 8844020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication.
    Li CJ; Zhang LJ; Dezube BJ; Crumpacker CS; Pardee AB
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1839-42. PubMed ID: 8446597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element.
    Li G; Lisziewicz J; Sun D; Zon G; Daefler S; Wong-Staal F; Gallo RC; Klotman ME
    J Virol; 1993 Nov; 67(11):6882-8. PubMed ID: 8411393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.